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Summary 
Tumor intrafractional motion deteriorates radiation therapy efficacy. This report 
presents new data on prostate and lung tumor 6 degrees-of- freedom motion 
measured by kilovoltage intrafraction monitoring. Prostate and lung tumors rotated 
more than 5o for about a third of time. Different patterns of rotation and respiration- 
induced tumor rotation were observed. This study is important for designing a 6 
degrees-of-freedom tumor motion adaptation system to improve treatment 
conformality and reduce margins in radiation therapy. 
  
 Abstract 
Purpose: Tumor positional uncertainty has been identified as a major issue that 
deteriorates the efficacy of radiation therapy. Tumor rotational movement, which is not 
well understood, can result in significant geometric and dosimetric inaccuracies. The 
objective of this study was to measure 6 degrees-of-freedom (6 DoF) prostate   and 
lung tumor motion, focusing on the more novel rotation, using kilovoltage intra- 
fraction monitoring (KIM). 
Methods and Materials: Continuous kilovoltage (kV) projections of tumors with gold 
fiducial markers were acquired during radiation therapy for 267 fractions from 10 
prostate cancer patients and immediately before or after radiation therapy for 50 
fractions from 3 lung cancer patients. The 6 DoF motion measurements were 
determined from the individual 3-dimensional (3D) marker positions, after using 
methods to reject spurious and smooth noisy data, using an iterative closest point 
algorithm. 
Results: There were large variations in the magnitude of the tumor rotation among 
different fractions and patients. Various rotational patterns were observed. The average 
prostate rotation angles around the left-right (LR), superior-inferior (SI), and anterior- 
posterior (AP) axes were 1.0 ±  5.0o, 0.6  ±  3.3o, and 0.3  ±  2.0o, respectively. For 35% 
of the time, the prostate rotated more than 5o about the LR axis, indicating the need for 
intrafractional adaptation during radiation delivery. For lung patients, the average LR, 
SI, and AP rotation angles were 0.8  ± 4.2o,  −0.8    ± 4.5o, and 1.7  ±  3.1o, respectively. 
For about 30% of the time, the lung tumors rotated more than 5o around the SI axis. 
Respiration-induced rotation was detected in 2 of the 3 lung patients. 
Conclusions: The prostate and lung tumors were found to undergo rotations of more 
than 5o for about a third of the time. The lung tumor data represent the first 6 DoF 
tumor motion measured by kV images. The 6 DoF KIM method can enable rotational 
and translational adaptive radiation therapy and potentially reduce treatment margins. 
 Introduction 
 
Thoracic, abdominal, and pelvic tumors are not static inside the human body; they undergo 
translational and rotational motion. Uncorrected tumor movement can cause the tumor to become 
misaligned with the radiation beam, compromising cancer control and increasing normal tissue 
toxicity. Methods of correcting for intrafractional tumor translation have previously been reported 
(1-3). However, increasing evidence suggests that intrafractional tumor motion corrections 
should be applied not only to tumor translation but also to rotation (4, 5). It has previously been 
shown that a small off-center rotation of an elongated target can result in a displacement of 13% 
of the target beyond the planning tumor volume (PTV) (4) and that uncorrected prostate tumor 
rotations of 15o can result in a 12% underdose to the tumor (6). As tighter PTV margins are 
applied and fractionation regimens are shortened (largely owing to translational compensation), 
factors such as tumor rotation will become the dominant concern for accurate tumor targeting. 
The aim of this study was to quantify the intrafractional tumor rotation in patients with prostate 
and lung cancer and to understand the requirements for a real-time tumor rotation adaptation 
system. 
Intrafractional tumor rotations of the prostate have previously been measured using 
electromagnetic tracking (Calypso transponder) (5, 7) and MV images with gold fiducial 
markers (8). Each study reported similar magnitudes of prostate rotation, with the predominant 
rotation being about the LR axis. The only previous study regarding lung tumor rotation 
reported slow breathing measurements with magnetic resonance imaging (MRI), wherein a 
maximum rotation of more than 45o was observed (9). Novel monitoring methods and further 
investigation into the intrafractional tumor rotation are needed. 
A recently developed method that is capable of monitoring real-time tumor motion is kilovoltage 
intrafraction monitoring (KIM) (10). KIM demonstrated high accuracy under clinical conditions, 
and a comparison between KIM and Calypso was summarized by Ng et al (11). The current work 
extends the KIM system by including tumor rotation monitoring. Tumor rotation calculations 
using KIM have been previously carried out by the iterative closest point (ICP) algorithm but 
have been applied to only 1 fraction of each of 10 prostate cancer patients (12). The purpose of 
this study was to perform 6 degrees-of-freedom (DoF) prostate and lung tumor motion 
measurements using KIM. 
 
Methods and Materials 
 
Rotation measurement 
 
An overview of the 6 DoF monitoring method is shown in Figure 1. Briefly, a series of 2-
dimensional (2D) x-ray projections are acquired during radiation therapy by a single kV imager 
(Fig. 1A and 1B). Our in-house software will segment the gold fiducial markers (Fig. 1C) and 
reconstruct their 3- dimensional (3D) positions using the maximum likelihood estimation of a 
3D probability density function (Fig. 1D) (10). With the marker 3D position information, tumor 
rotation and translation are calculated by the ICP algorithm (12, 13) (Fig. 1E). The ICP algorithm 
performs matching for each fiducial marker based on the nearest neighbor algorithm and 
generates a rotation matrix and translation vector (14). Rotation angles about 3 orthogonal axes 
(LR, SI, AP) were determined with the pivot set at the centroid of the 3 markers. In this study, 
rotation angles were calculated between the current time and a reference time at the beginning of 
each fraction to determine intrafraction rotation and also at the beginning of treatment to quantify 
the interfraction and intrafraction rotation. Inasmuch as tumor translation has been much more 
widely studied, and the patient database used in this study have been published for the prostate (11) 
and the lung (15), the results here focus on the rotation measurements. 
 
Patient database 
 
In the KIM prostate tumor motion study, 10 prostate cancer patients had 3 cylindrical gold 
fiducial markers (1 x 3 mm) implanted and treated with fractionated double-arc volumetric 
modulated arc therapy (11). Continuous kV images were acquired using a kV imager (OBI, 
Varian) when the treatment beam was on. The exposure parameters were 125 kVp, 80 mA,and 
13 ms. To reduce patient dose, a field size of 6 x 6 cm2 was chosen as the minimum necessary 
to cover the marker positions from all gantry angles. The image frequency was 5 Hz or 10 
Hz depending on the desired image quality. The imaging dose from KIM was quantified to 
be 185 mGy over the course of a prostate intensity- modulated radiation therapy for 120 kV 
(1.04 mAs) imaging at 1 Hz, a small portion of the total treatment dose (16). In a 7-lung tumor 
motion study, 4 patients had 3 markers (3 patients) or 4 markers (1 patient) implanted. 
However, 2 of these patients had 2 markers implanted within close proximity, 1 with 3 markers 
and 1 with 4 markers. Differentiation between these markers was not possible (15). Therefore, 1 
of the 3-marker patients was excluded, leaving 3 patients remaining. No patients were excluded 
for image quality; however, 11 of the 61 fractions were excluded because of poor image quality. 
The tumor location in 2 patients was the right hilum, and in the third it was the left lower lobe. 
Fiducial gold coils (0.35 10 or 20 mm) were implanted into the lung. For each of the treatment 
fractions, 8-minute kV imaging sequences, corresponding to the duration of a typical radiation 
treatment, were taken by the kV imager at 10 Hz immediately before or after treatment. The 
exposure parameters were 125 kVp, 20 mA, and 20 ms per projection. We estimate the lung 
imaging dose (more projections, less dose per projection) for a 6 x 6 cm2 field size (reducing 
the field size to only show the lung markers) at 1 Hz to also be approximately 190 mGy. 
 
Data acceptance and noise filtering methods 
 
The ICP algorithm takes individual 3D marker position as input. However, the accuracy of the 
marker coordinates is subject to variable image quality, the accuracy of the 2D marker 
segmentation, and the 3D reconstruction algorithm. To improve marker position fidelity for each 
fraction before calculating tumor rotation, we implemented 4 methods to reject spurious and 
smooth noisy data. Each step is briefly described here. 
 
 
Correlation 
 
In the marker segmentation step, marker position was determined as the position with the highest 
normalized cross-correlation between the template and the projection image (17). Data are prone 
to noise if the correlation is low. 
 
In this study, the correlation threshold value was set at 0.3 for prostate patients (0.3% of data 
removed) and 0.4 for lung patients (8.1% removed). 
Despiking 
 
A phase-space thresholding method (18) was used to remove spikes from the marker trajectory. 
Normally, valid data are tightly clumped within an ellipsoid cloud in phase space (3D plots of velocity, 
u, and approximations of acceleration and jerk, ∆u and ∆2u, respectively). Spikes or the points outside 
the phase-space thresholds are iteratively removed. A universal threshold parameter √2 ln𝑛 
Was applied to the lung data series (7.3% removed), and 2 times the universal threshold was 
applied to the prostate data series (0.6% removed). 
 
Rigidity 
 
The area defined by vertices of the triangle formed by the 3 fiducial markers was calculated over 
time. Tumor rigidity was calculated based on the change in the area of the triangles. The data 
were regarded as being false positive if the change in the triangle area was beyond a set threshold. 
For the prostate, the rigidity threshold was set as 5% (0.1% removed). For lung patients, the 
rigidity threshold was set at 10% because larger changes are expected from respiratory induced 
motion in the lung (0.1% removed). 
 
L1 trend filtering 
 
The L1 trend filtering method was used to smooth the original noisy data series. The L1 filtering 
method can be used for real-time trend filtering with a smaller filter window size. It generates 
trend estimates that are smooth in the sense of being piecewise linear. For a given time series 
yt, t = 1,……,n with an underlying slowly varying trend xt, L1 chooses the trend estimate as the 
minimizer of the weighted sum objective function 
(19). 
 
A regularization parameter l controls the tradeoff between the smoothness of the trend and the size of 
the residual. In this work, λ was set to 0.1. 
 
Sensitivity analysis 
Each of the 4 steps involves setting a parameter. The ﬁnal values were determined heuristically with 
the goal of maintaining the maximum amount of original data while removing obvious noise and 
spurious results. A sensitivity analysis was performed by increasing and decreasing the parameter 
values in each of the 4 steps by at least ±33%. Even with these large changes, the mean value changed 
by ≤0.1°and standard deviation (SD) ≤0.15°, indicating that the mean and SD are not sensitive to the 
selection of the parameters. The differences lie in the amount of data that were removed (≤ 34%) and 
the values of the maximal and minimal rotation. 
  
 
 
Results 
 
Prostate and lung tumor rotation 
 
Continuous prostate and lung rotation was calculated.  Table 1 lists the mean and SD of 
intrafraction and interfraction for prostate and lung from this study and also compares the 
current results with those of previous studies (7-9, 12, 20, 21). 
For prostate cancer patients, the SD of interfractional and intrafractional rotation was 5.5°, 
3.0°, and 2.0° about the LR, SI, and AP axes, respectively, which was larger than 
intrafractional rotation. Prostate rotation about the LR axis was the most predominant of the 3 
rotation axes and was in agreement with previous published results. For lung cancer patients, 
the SD of interfractional and intrafractional rotation was 2.9o, 4.6o and 3.0o about the LR, SI, 
and AP axes, respectively. Rotation around the SI axis was the major rotation among all 3 
axes. 
The prostate and lung tumor interfraction and intra- fraction translation and rotation distributions 
are shown in the matrix diagonal of Figure 2. The prostate rotated more than 5o about the LR 
axis for more than 35% of the time, highlighting the desirability of applying tumor rotational 
corrections during radiation delivery. Lung tumors were found to rotate more than 5o about the 
SI axis for about 30% of the time. Prostate and lung tumor rotations of more than 30o were 
observed, but the exact maximal rotation angle depends strongly on the data acceptance and 
noise filtering methods applied. If stricter thresholds or higher λ values in the L1 filtering 
method were applied, more data would be rejected, and the trajectory would become smoother, 
thus resulting in a reduced maximum rotation angle. 
The kV images of a rotated prostate and lung were selected to show intrafractional tumor 
rotation in Figure 3. The images are of the same prostate and lung taken at the same gantry 
angle at different time points.  
Rotation patterns 
 
Tumors were observed to undergo variable rotational behavior over time among the patients. 
Rotation analogues of the translational motion types described initially by Kupelian et al (3) for 
Calypso and Ng et al (11) for KIM were observed. These classifications are important for 
designing the rotation adaptation system because the management of each pattern of rotation is 
different. Ex- amples of these rotation patterns are shown in Figure 4 for prostate and lung. 
The magnitude of prostate and lung tumor rotation also differed greatly from fraction to fraction 
and patient to patient. The dosimetric effect of tumor rotation is therefore expected to be 
significantly larger for a given subgroup of patients. Of particular note are tumors within the class 
of lung persistent rotation (Fig. 4), in which >6 of LR rotation was observed for most of the 
treatment time, indicating a large geometric uncertainty. 
 
Respiratory component in lung tumor rotation 
 
From the lung rotation traces in Figure 4, respiratory cycles could be readily observed. To further 
analyze the effect of breathing in lung tumor rotation, the power spectrum cor- responding to SI 
rotation was plotted for each patient. 
Peaks at ~0.3 Hz were observed in the power spectrum for 2 lung patients (Fig. 5); 0.3 Hz is 
equivalent to a signal cycle of every 3.3 seconds, which is a typical respiratory cycle for patients. 
However, this phenomenon was not observed in patient 2, which may be a result of the tumor 
location (left lower lobe vs right hilum) and could also be a result of atelectasis experienced by 
the patient during the treatment period (15). Interestingly, no predominant peaks were observed 
around 0.5 to 1 Hz, indicating that the cardiac cycle did not introduce tumor rotation for these 
 - 
patients. 
 
Correlation of 6 DoF tumor motion 
 
Pearson linear correlation coefficients were calculated be- tween all sets of tumor 6 DoF motion 
for the prostate and lung patients separately (Fig. 2). Histograms of each 3 DoF translation (mm) 
and 3 DoF rotation (o) are along the matrix diagonal; scatter plots of variable pairs appear off- 
diagonal with the unit of millimeter. 
High correlations were observed between the prostate AP translation and the SI translation 
(0.89), between the lung tumor AP and the SI translation (0.63), and between the AP translation 
and rotation (0.62). These 6 DoF tumor motion correlation values are population based, and the 
correlations are different for individual patients. 
 
Discussion 
 
In this report, we describe 6 DoF tumor motion measurements using the KIM method, focusing on 
the more novel rotational motion results. Tumor rotation about 3 axes was calculated by 
determining the position of gold fiducial markers in successive 2D kV images acquired 
continuously during treatment or before or after treatment. This method is widely applicable 
because the majority of radiation therapy linear accelerators purchased today incorporate gantry-
mounted kV imagers. In addition, the implantation of gold fiducial markers is the current clinical 
standard of care for prostate patient setup before radiation therapy (22). The tumor motion 
monitoring and adaptation based on the KIM method can be performed at no additional cost in 
terms of linac hardware; however, implanting lung fiducial markers does require additional 
procedures and may introduce side effects. 
 
We show that for both prostate and lung tumors, the SDs of interfractional and intrafractional 
rotation are larger than intrafractional rotation because of greater day-by-day tumor position 
variation. Our results also demonstrate that intrafractional tumor rotation during radiation therapy 
can be unpredictable, with rotation patterns ranging greatly from small rotation, continuous 
rotation, transient rotation, persistent rotation, and high-frequency rotation to erratic rotation, or 
a combination thereof. Tumor intrafractional motion caused by the patient’s spontaneous rectum 
and bladder filling, flatulence, muscle contractions, and breathing is hard to exclude. Thus, the 
adaptation to intrafractional tumor motion is best handled by modern tracking techniques, such 
as dynamic multileaf collimator tracking, Cyberknife, and Gimbaled system (23). 
 
Diaphragm   (24)  and   lung   tumor   rotation (25)  was observed in 4-dimensional computed 
tomography but not quantified. Given the complexity of lung motion, we present the first 
attempt to demonstrate high-frequency respiratory-induced rotation from general lung 
movement. The rotation power spectrum peak at 0.3 Hz (or 3.3 seconds), which is a typical 
breathing cycle, indicates that there is a respiratory component to lung tumor rotational 
movement. Our 50 fractions of images show that the strength of the respiratory signal in rotation 
appears to depend on thetumor position within the lung, although a strong conclusion would 
need more patient data; only 3 patients are included in this analysis. The effect of marker 
position deformation was accounted for by a data acceptance method: rigidity in this study. 
Tumor rigidity was calculated based on the change in the area of the triangles. We showed that 
for intrafractional rotation, less than 0.1% of data was removed by rigidity thresholding. 
 
The KIM measured prostate rotation is similar to the values measured by other methods (Table 
1). The lung tumor rotation result is different from the MRI measured result, and this could be 
due to the different measurement methods. The KIM rotation calculation method is highly 
 
accurate. First, the KIM method achieved 0.46 mm accuracy in the prostate cancer patient 
clinical trial (11). Second, the root mean square error of the ICP algorithm in a simulation study 
has previously been reported as 0.004o (12). However, the present study was affected by the kV 
image quality. Markers are generally more difficult to identify in kV images taken through the 
lateral side of a patient, and their identification is especially difficult in larger patients because 
of increased photon scattering. Furthermore, for certain lung patients, the spine, medical wires, 
and other objects can partially obstruct the radiation beam and cause marker segmentation 
problems at certain projection angles. With extra image quality enhancement steps, the marker-
based localization method can be greatly improved. 
 
Monitoring tumor rotation is the ﬁrst step toward real-time rotation adaptive radiation therapy. 
Independent studies have shown that considering tumor rotation reductions in the treatment margin 
by 2 to 3 mm is possible (20, 26). There are higher accuracy requirements for the emerging stereo-
tactic body radiation therapy (SBRT), wherein the radiation treatment is hypofractionated and each 
fraction delivers a higher dose of radiation over a longer period of time (27). The ability to track 
target tumor motion by considering not only translation but also rotation could potentially address 
the high precision requirement of SBRT. 
 
 
Conclusions 
This study examined the use of a gantry-mounted kV imager to measure 6 DoF tumor motion by 
KIM. The lung tumor data represent the ﬁrst 6 DoF motion measured by kV images. The prostate 
tumor data represent the most comprehensive 6 DoF motion measurements with KIM. In both 
prostate and lung cancer patients, tumors were found to undergo rotations of more than 5° for about 
a third of the total treatment time. Various of rotation patterns were observed, with LR rotation for 
prostate and SI rotation for lung patients having the highest magnitude. In as much as gantry-mounted 
kV imagers are present in most new cancer radiation therapy systems, there is potential for the tech-
nique to be widely used. The 6 DoF KIM method can enable rotational and translational adaptive 
radiation therapy and potentially reduce treatment margins. 
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